IMS (WAR:IMS) ROCE % : 16.72% (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is IMS ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. IMS's annualized ROCE % for the quarter that ended in Mar. 2024 was 16.72%.

IMS ROCE % Historical Data

The historical data trend for IMS's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMS ROCE % Chart

IMS Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

36.76

13.14

22.68

22.69

26.87

IMS Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															21.32	34.00	29.91	28.86	16.72

IMS ROCE % Calculation

IMS's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	13.424	/	( ( (74.225 - 32.738)	+	(88.569 - 30.138) )	/ 2 )
	=	13.424	/	( (41.487	+	58.431)	/ 2 )
	=	13.424	/	49.959
	=	26.87 %

IMS's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	9.88	/	( ( (88.569 - 30.138)	+	(79.688 - 19.91) )	/ 2 )
	=	9.88	/	( ( 58.431	+	59.778 )	/ 2 )
	=	9.88	/	59.1045
	=	16.72 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

IMS (WAR:IMS) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

IMS ROCE % Related Terms

Thank you for viewing the detailed overview of IMS's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

IMS (WAR:IMS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Communication Services » Media - Diversified » IMS SA (WAR:IMS) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ulica Pu?awska 366, Warsaw, POL, 02-819

Website

http://www.ims.fm

IMS SA offers sensory marketing services in Poland. The company operates in the media and modern technology segment. The company's services include Audio marketing, Digital Signage, Scent marketing, Event marketing, Technology and development for sensory marketing.

IMS (WAR:IMS) Headlines

From GuruFocus

Weekly Insider Sells Highlight: IMS, NOW, BMY, EA

By James Xiao James Xiao • 08-11-2015

5 Companies Reach 52-Week Highs

By yifan900 yifan900 • 02-13-2018

The Big 3: Larry Robbins' Top 2nd-Quarter Buys

By James Li James Li • 08-16-2016

Well-Known Companies Reach 52 Week Highs

By yifan900 yifan900 • 10-11-2016

Healthcare Informatics: A Value Investor's Perspective

By Thomas Macpherson Thomas Macpherson • 10-23-2015